Contemporary OB/GYN Staff

Articles by Contemporary OB/GYN Staff

Analysis by the United States Food and Drug Administration (FDA) of compounded 17α-hydroxyprogesterone caproate (17P) shows the samples meet the potency and total purity standards for Makena, the branded version of the drug. Testing was done on 16 samples of bulk 17P active pharmaceutical ingredients (API) in response to questions from K-V Pharmaceuticals, Makena’s sponsor, about potency and purity of the compounded product.

Long-acting reversible contraceptives (LARCs) are significantly more effective than oral contraceptive pills, rings, or patches in preventing unintended pregnancy in adolescent girls and young women, a large prospective cohort study from Washington University School of Medicine reports.